Skip to main content
. 2026 Jun 24;14(7):1433. doi: 10.3390/biomedicines14071433
CVD cardiovascular disease
MI myocardial infarction
HF heart failure
IS ischemic stroke
lncRNAs long non-coding RNAs
miRNAs microRNAs
MALAT1 metastasis-associated lung adenocarcinoma transcript 1
STEMI ST-elevation myocardial infarction
MACE major adverse cardiovascular event
ceRNA competing endogenous RNA
COX-2 cyclooxygenase-2
COPD chronic obstructive pulmonary disease
MACCE major adverse cardiovascular and cerebrovascular events
TC total cholesterol
CAD coronary artery disease
PBMC peripheral blood mononuclear cell
PCI percutaneous coronary intervention
T2DM type 2 diabetes mellitus
LV left ventricle
MMA Military Medical Academy
LVEDD LV end-diastolic diameter
LVESD LV end-systolic diameter
LVEF LV ejection fraction
HFrEF heart failure with reduced ejection fraction
eQTLs expression quantitative trait loci
LD linkage disequilibrium
GWAS genome-wide association study
BMI body mass index
SD standard deviation
HWE Hardy–Weinberg equilibrium
OR odds ratio
CI confidence interval
HDLC high-density lipoprotein cholesterol
LDLC low-density lipoprotein cholesterol
TG triglycerides
CKmax peak creatine kinase level
CK-MBmax peak creatine kinase–MB level
Tnmax peak troponin level
CRP C-reactive protein
UFH unfractionated heparin
LMWH low-molecular-weight heparin
ns not significant
N/A not applicable
ROS reactive oxygen species
MIRI myocardial ischemia/reperfusion injury